Ho PY - Search Results

1

Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice.

Ho PY, Yeh TK, Yao HT, Lin HL, Wu HY, Lo YK, Chang YW, Chiang TH, Wu SH, Chao YS, Chen CT. Ho PY, et al. Int J Pharm. 2008 Jul 9;359(1-2):174-81. doi: 10.1016/j.ijpharm.2008.04.013. Epub 2008 Apr 16. Int J Pharm. 2008. PMID: 18513900

2

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities.

Hu CB, Chen CP, Yeh TK, Song JS, Chang CY, Chuu JJ, Tung FF, Ho PY, Chen TW, Lin CH, Wang MH, Chang KY, Huang CL, Lin HL, Li WT, Hwang DR, Chern JH, Hwang LL, Chang JY, Chao YS, Chen CT. Hu CB, et al. Among authors: ho py. Cancer Sci. 2011 Jan;102(1):182-91. doi: 10.1111/j.1349-7006.2010.01744.x. Epub 2010 Oct 12. Cancer Sci. 2011. PMID: 21040217 Free article.

3

Inhibition of human vascular endothelial cells proliferation by terbinafine.

Ho PY, Liang YC, Ho YS, Chen CT, Lee WS. Ho PY, et al. Among authors: ho ys. Int J Cancer. 2004 Aug 10;111(1):51-9. doi: 10.1002/ijc.20039. Int J Cancer. 2004. PMID: 15185342 Free article.

4

Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10).

Liu Y, Wu J, Ho PY, Chen LC, Chen CT, Liang YC, Cheng CK, Lee WS. Liu Y, et al. Among authors: ho py. Cancer Lett. 2008 Nov 28;271(2):294-305. doi: 10.1016/j.canlet.2008.06.016. Epub 2008 Jul 22. Cancer Lett. 2008. PMID: 18649995

5

In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest.

Lee WS, Chen RJ, Wang YJ, Tseng H, Jeng JH, Lin SY, Liang YC, Chen CH, Lin CH, Lin JK, Ho PY, Chu JS, Ho WL, Chen LC, Ho YS. Lee WS, et al. Among authors: ho wl, ho py, ho ys. Int J Cancer. 2003 Aug 10;106(1):125-37. doi: 10.1002/ijc.11194. Int J Cancer. 2003. PMID: 12794767 Free article.

6

Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.

Zhong WB, Hsu SP, Ho PY, Liang YC, Chang TC, Lee WS. Zhong WB, et al. Among authors: ho py. Biochem Pharmacol. 2011 Dec 1;82(11):1663-72. doi: 10.1016/j.bcp.2011.08.021. Epub 2011 Sep 2. Biochem Pharmacol. 2011. PMID: 21907187

7

Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma.

Tsai YC, Yeh CH, Tzen KY, Ho PY, Tuan TF, Pu YS, Cheng AL, Cheng JC. Tsai YC, et al. Among authors: ho py. Eur J Cancer. 2013 Apr;49(6):1458-66. doi: 10.1016/j.ejca.2012.10.020. Epub 2012 Nov 12. Eur J Cancer. 2013. PMID: 23153706

8

Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats.

Yang SC, Yang HY, Yang YC, Peng HC, Ho PY. Yang SC, et al. Among authors: ho py. Eur J Nutr. 2013 Mar;52(2):601-8. doi: 10.1007/s00394-012-0362-0. Epub 2012 May 3. Eur J Nutr. 2013. PMID: 22552991

9

Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor.

Lin SY, Lee WR, Su YF, Hsu SP, Lin HC, Ho PY, Hou TC, Chou YP, Kuo CT, Lee WS. Lin SY, et al. Among authors: ho py. Angiogenesis. 2012 Dec;15(4):671-83. doi: 10.1007/s10456-012-9289-6. Epub 2012 Jul 29. Angiogenesis. 2012. PMID: 22843228

10

ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.

Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK. Ho PY, et al. Urol Oncol. 2013 Oct;31(7):1367-77. doi: 10.1016/j.urolonc.2012.01.015. Epub 2012 Mar 13. Urol Oncol. 2013. PMID: 22417627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page